E-MTAB-7722 - The LL-100 panel: 100 DSMZ cell lines for blood cancer studies; WES

Released on 28 May 2019, last updated on 1 November 2019
Homo sapiens
Samples (100)
Protocols (4)
For many years, immortalized cell lines have been used as model systems for cancer research. Cell line panels were established for basic research and drug development, but did not cover the full spectrum of leukemia and lymphoma. Therefore, we now developed a novel panel (LL-100), 100 cell lines covering 22 entities of human leukemia and lymphoma including T-cell, B-cell and myeloid malignancies. Importantly, all cell lines are unequivocally authenticated and assigned to the correct tissue. Cell line samples were proven to be free of mycoplasma and virus contamination. Whole exome sequencing (WES) and RNA sequencing (RNA-seq) of the hundred authenticated leukemia-lymphoma cell lines were conducted with a uniform methodology to complement existing data on these publicly available cell lines. This part captures WES. This data set will be useful for understanding the function of oncogenes and tumor suppressor genes and to develop targeted therapies.
Experiment types
DNA-seq, cell type comparison design, disease state design
The LL-100 panel: 100 cell lines for blood cancer studies. Quentmeier H, Pommerenke C, Dirks WG, Eberth S, Koeppel M, MacLeod RAF, Nagel S, Steube K, Uphoff CC, Drexler HG. 9(1):8218 (2019), PMID:31160637
Exp. designProtocolsVariablesProcessedSeq. reads
Investigation descriptionE-MTAB-7722.idf.txt
Sample and data relationshipE-MTAB-7722.sdrf.txt